Literature DB >> 861147

Changes in sensitivity to radiation and ICRF 159 during the life of monolayer cultures of EMT6 tumour line.

I W Taylor, N M Bleehen.   

Abstract

The response of EMT6 mouse tumour cells to ICRF 159, both with and without X-radiation, has been measured during the life of monolayer cultures. The cytotoxic effect of ICRF 159 was found to be proliferation-dependent. Flow cytofluorimetry studies of cell cycle distribution showed that ICRF 159 prevented cell division while allowing DNA synthesis to continue. This anti-mitotic action and the cytotoxic effect of the drug were found to be closely related. Increased sensitivity to X-radiation was observed in cultures pretreated for 24 h with 200 microgram/ml ICRF 159 In exponential and early plateau cultures this was seen as a reduced shoulder of the survival curve. In late plateau cultures there was no apparent reduction of the shoulder, but an increase in slope.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 861147      PMCID: PMC2025490          DOI: 10.1038/bjc.1977.92

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  15 in total

1.  X-ray damage and recovery in mammalian cells in culture.

Authors:  M M ELKIND; H SUTTON
Journal:  Nature       Date:  1959-10-24       Impact factor: 49.962

2.  Combined treatment of soft tissue and osteosarcomas by radiation and ICRF 159.

Authors:  R D Ryall; I W Hanham; K A Newton; K Hellmann; D M Brinkley; O K Hjertaas
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

3.  Synergism of ICRF 159 and radiotherapy in treatment of experimental tumors.

Authors:  K Hellmann; G E Murkin
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

4.  Combined treatment of the Walker tumour with radiotherapy and ICRF 159.

Authors:  K Norpoth; A Schaphaus; H Ziegler; U Witting
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1974

5.  Histological analysis of the antimetastatic effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane.

Authors:  A J Salsbury; K Burrage; K Hellmann
Journal:  Cancer Res       Date:  1974-04       Impact factor: 12.701

6.  Cumulative cytostatic effect of ICRF 159.

Authors:  R C Hallowes; D G West; K Hellmann
Journal:  Nature       Date:  1974-02-15       Impact factor: 49.962

7.  Cell proliferation and the action of cytotoxic agents on haemopoietic tissue.

Authors:  N M Blackett; K Adams
Journal:  Br J Haematol       Date:  1972-12       Impact factor: 6.998

8.  Metastases and the normalization of tumour blood vessels by ICRF 159: a new type of drug action.

Authors:  A W Le Serve; K Hellmann
Journal:  Br Med J       Date:  1972-03-04

9.  Effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane on tumor blood vessels and its relationship to the antimetastatic effect in the Lewis lung carcinoma.

Authors:  S E James; A J Salsbury
Journal:  Cancer Res       Date:  1974-04       Impact factor: 12.701

10.  Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining.

Authors:  A Krishan
Journal:  J Cell Biol       Date:  1975-07       Impact factor: 10.539

View more
  8 in total

Review 1.  New cancer chemotherapy drugs in Europe.

Authors:  G Mathé; L M van Putten
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

2.  Responses of liver metastases to radiotherapy and razoxane.

Authors:  K Hellmann; M Goold; N Higgins; R H Phillips
Journal:  J R Soc Med       Date:  1992-03       Impact factor: 5.344

3.  The cytokinetic and cytotoxic effects of ICRF-159 and ICRF-187 in vitro and ICRF-187 in human bone marrow in vivo.

Authors:  R H Wheeler; D J Clauw; R B Natale; R W Ruddon
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

4.  ICRF-159 enhancement of radiation response in combined modality therapies. I. Time/dose relationships for tumour response.

Authors:  C J Kovacs; M J Evans; L L Schenken; D R Burholt
Journal:  Br J Cancer       Date:  1979-05       Impact factor: 7.640

5.  Interaction of ICRF 159 with radiation, and its effect on sub-lethal and potentially lethal radiation damage in vitro.

Authors:  I W Taylor; N M Bleehen
Journal:  Br J Cancer       Date:  1977-10       Impact factor: 7.640

6.  Razoxane-induced polyploidy.

Authors:  I W Taylor; N M Bleehen
Journal:  Br J Cancer       Date:  1978-07       Impact factor: 7.640

7.  ICRF-159 enhancement of radiation response in combined modality therapies. II. Differential responses of tumour and normal tissues.

Authors:  C J Kovacs; M J Evans; D R Burholt; L L Schenken
Journal:  Br J Cancer       Date:  1979-05       Impact factor: 7.640

8.  Combination therapy of a mouse sarcoma using razoxane and electron irradiation.

Authors:  M B Grimshaw; R W Davies; W S Hall
Journal:  Br J Cancer       Date:  1981-07       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.